Why the study?
There is a paucity of literature on the clinical implications of ventricular arrhythmias in the context of cardiac amyloidosis, and management guidelines remain lacking.
Design
Review of current literature
Authors
Loading...
Supports individualized VA therapy in cardiac amyloidosis; leaves open optimal ICD use pending large prospective trials.
This review highlights the multifaceted management of ventricular arrhythmias in cardiac amyloidosis, noting the controversial role of ICDs and the need for further large-scale studies to define treatment paradigms.
Khanna et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: